A day after the DOJ said it would ease restrictions on medical marijuana, the FDA moves to fast-track some experimental psychedelic drugs for review. They’re looking at three drugs for treatment-resistant depression, major depressive disorder, and PTSD. NBC’s Anne Thompson reports.
For more context and news coverage of the most important stories of our day, click here:
» Subscribe to NBC News:
» Subscribe to Here’s the Scoop podcast:
Every day, NBC News helps people understand what’s happening and why it matters — through fact-based reporting, meaningful conversations, and powerful stories. From its leading news broadcasts — TODAY, NBC Nightly News, Meet the Press, and Dateline — to NBC News NOW, the 24/7 streaming news channel, plus chart-topping podcasts, the NBC News app, and NBCNews.com, NBC News keeps audiences informed and connected to the stories shaping our world.
Connect with NBC News Online!
NBC News App:
Breaking News Alerts:
Visit NBCNews.Com:
Find NBC News on Facebook:
Follow NBC News on Twitter:
Follow NBC News on Instagram:
#FDA #Health #Drug #Psychedelic
source
